Ibrexafungerp
Kathryn Dzintars, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Ibrexafungerp is indicated for the treatment of
vulvovaginal candidiasis
(VVC) in adults and post-menarchal pediatric females.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2024 Unbound Medicine, Inc. All rights reserved